Last reviewed · How we verify

NCT06810713

Evaluation of a Training for Healthcare Providers in Supporting Men Experiencing Suicidal Ideation

Completed NA Last updated 13 April 2026
What this trial tests

NA trial testing Gatekeeper training (e-learning) in Suicide in 119 participants. Completed in 13 July 2025.

Timeline
27 May 2025
Primary endpoint
13 July 2025
13 July 2025

Quick facts

Lead sponsorUniversity Ghent
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeprevention
Enrollment119
Start date27 May 2025
Primary completion13 July 2025
Estimated completion13 July 2025
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

University Ghent

Who can join

18 and older, any sex, with Suicide or Suicidal Ideation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to assess how healthcare providers perceive and evaluate the developed e-learning. The findings will inform potential adjustments to enhance the e-learning as needed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Gatekeeper training (e-learning)

Trials testing the same drug.

Other recruiting trials for Suicide

Currently open trials in the same condition.

Other University Ghent trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06810713.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing